Jul 30 |
MannKind Corporation to Hold 2024 Second Quarter Financial Results Conference Call on August 7, 2024
|
Jul 23 |
MannKind Corporation: Finally Gaining Traction
|
Jul 17 |
Is There An Opportunity With MannKind Corporation's (NASDAQ:MNKD) 49% Undervaluation?
|
Jul 16 |
All You Need to Know About MannKind (MNKD) Rating Upgrade to Buy
|
Jul 16 |
Is MannKind (MNKD) Outperforming Other Medical Stocks This Year?
|
Jul 16 |
MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?
|
Jun 22 |
INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific Sessions
|
Jun 20 |
Recent 5.2% pullback isn't enough to hurt long-term MannKind (NASDAQ:MNKD) shareholders, they're still up 327% over 5 years
|
Jun 5 |
Inhale-3 Study Results to be Presented During a 90-Minute Symposium on Saturday, June 22 at the American Diabetes Association’s 84th Scientific Sessions
|
May 29 |
Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation
|